vs
Orange County Bancorp, Inc.（OBT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Orange County Bancorp, Inc.的1.1倍（$35.5M vs $33.0M），Orange County Bancorp, Inc.净利率更高（37.6% vs -304.2%，领先341.9%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 20.6%），Orange County Bancorp, Inc.自由现金流更多（$41.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 14.3%）
奥兰治县银行控股公司注册于美国特拉华州，主要在纽约州开展业务，为个人消费者、小微企业及中型企业客户提供全面的零售与商业银行服务，涵盖存款账户、各类贷款、财富管理解决方案等金融产品。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
OBT vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $33.0M | $35.5M |
| 净利润 | $12.4M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 41.4% | -304.8% |
| 净利率 | 37.6% | -304.2% |
| 营收同比 | 20.6% | 681.7% |
| 净利润同比 | 73.5% | 39.6% |
| 每股收益（稀释后） | $0.94 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $33.0M | $35.5M | ||
| Q3 25 | $33.7M | $5.2M | ||
| Q2 25 | $32.5M | $19.2M | ||
| Q1 25 | $28.0M | $14.7M | ||
| Q4 24 | $27.4M | $4.5M | ||
| Q3 24 | $27.1M | $26.1M | ||
| Q2 24 | $27.9M | $14.4M | ||
| Q1 24 | $25.3M | $13.8M |
| Q4 25 | $12.4M | $-108.1M | ||
| Q3 25 | $10.0M | $-162.3M | ||
| Q2 25 | $10.5M | $-171.9M | ||
| Q1 25 | $8.7M | $-202.5M | ||
| Q4 24 | $7.2M | $-178.9M | ||
| Q3 24 | $3.2M | $-95.8M | ||
| Q2 24 | $8.2M | $-97.5M | ||
| Q1 24 | $9.3M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 41.4% | -304.8% | ||
| Q3 25 | 38.6% | -3327.6% | ||
| Q2 25 | 41.9% | -916.8% | ||
| Q1 25 | 40.3% | -1297.9% | ||
| Q4 24 | 32.8% | -4042.4% | ||
| Q3 24 | 14.8% | -377.1% | ||
| Q2 24 | 36.6% | -697.4% | ||
| Q1 24 | 45.9% | -698.4% |
| Q4 25 | 37.6% | -304.2% | ||
| Q3 25 | 29.7% | -3135.3% | ||
| Q2 25 | 32.2% | -894.2% | ||
| Q1 25 | 31.1% | -1373.3% | ||
| Q4 24 | 26.2% | -3935.5% | ||
| Q3 24 | 11.8% | -367.5% | ||
| Q2 24 | 29.4% | -676.6% | ||
| Q1 24 | 36.7% | -662.4% |
| Q4 25 | $0.94 | $-0.17 | ||
| Q3 25 | $0.75 | $-0.36 | ||
| Q2 25 | $0.87 | $-0.41 | ||
| Q1 25 | $0.77 | $-0.50 | ||
| Q4 24 | $0.64 | $-0.56 | ||
| Q3 24 | $0.28 | $-0.34 | ||
| Q2 24 | $0.73 | $-0.40 | ||
| Q1 24 | $0.82 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $284.4M | $1.1B |
| 总资产 | $2.7B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $284.4M | $1.1B | ||
| Q3 25 | $270.1M | $1.0B | ||
| Q2 25 | $252.6M | $919.1M | ||
| Q1 25 | $201.3M | $933.9M | ||
| Q4 24 | $185.5M | $1.0B | ||
| Q3 24 | $193.1M | $524.6M | ||
| Q2 24 | $177.5M | $584.4M | ||
| Q1 24 | $168.7M | $401.2M |
| Q4 25 | $2.7B | $1.5B | ||
| Q3 25 | $2.6B | $1.4B | ||
| Q2 25 | $2.6B | $1.3B | ||
| Q1 25 | $2.6B | $1.3B | ||
| Q4 24 | $2.5B | $1.4B | ||
| Q3 24 | $2.5B | $726.5M | ||
| Q2 24 | $2.5B | $775.9M | ||
| Q1 24 | $2.5B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $43.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $41.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 125.1% | -133.1% |
| 资本支出强度资本支出/营收 | 7.6% | 3.5% |
| 现金转化率经营现金流/净利润 | 3.53× | — |
| 过去12个月自由现金流最近4个季度 | $69.6M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $43.8M | $-46.1M | ||
| Q3 25 | $30.2M | $-117.4M | ||
| Q2 25 | $-5.0M | $-76.4M | ||
| Q1 25 | $4.8M | $-132.0M | ||
| Q4 24 | $34.6M | $-115.4M | ||
| Q3 24 | $10.2M | $-59.2M | ||
| Q2 24 | $9.3M | $-82.2M | ||
| Q1 24 | $2.3M | $-102.3M |
| Q4 25 | $41.3M | $-47.3M | ||
| Q3 25 | $29.6M | $-117.6M | ||
| Q2 25 | $-5.7M | $-79.6M | ||
| Q1 25 | $4.3M | $-133.8M | ||
| Q4 24 | $32.9M | $-116.7M | ||
| Q3 24 | $10.0M | $-63.8M | ||
| Q2 24 | $9.2M | $-83.4M | ||
| Q1 24 | $2.0M | $-109.0M |
| Q4 25 | 125.1% | -133.1% | ||
| Q3 25 | 87.8% | -2272.5% | ||
| Q2 25 | -17.5% | -413.9% | ||
| Q1 25 | 15.5% | -907.4% | ||
| Q4 24 | 120.0% | -2567.7% | ||
| Q3 24 | 36.7% | -244.6% | ||
| Q2 24 | 32.8% | -578.5% | ||
| Q1 24 | 7.9% | -789.9% |
| Q4 25 | 7.6% | 3.5% | ||
| Q3 25 | 1.8% | 4.7% | ||
| Q2 25 | 2.3% | 16.4% | ||
| Q1 25 | 1.8% | 12.4% | ||
| Q4 24 | 6.3% | 28.6% | ||
| Q3 24 | 1.1% | 17.5% | ||
| Q2 24 | 0.4% | 8.2% | ||
| Q1 24 | 1.0% | 48.2% |
| Q4 25 | 3.53× | — | ||
| Q3 25 | 3.01× | — | ||
| Q2 25 | -0.47× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 4.83× | — | ||
| Q3 24 | 3.19× | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 0.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
